Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function
Kirsteen J. Campbell(Cancer Research UK), Stephen W. G. Tait(University of Glasgow), Karen Blyth(Cancer Research UK), Matthew L. Winder(Cancer Research UK Scotland Institute), Susan Mason(Cancer Research UK Scotland Institute), Andrew H. Sims(Western General Hospital), Hannah Lawson(University of London), Catherine Cloix(Cancer Research UK), Sandeep Dhayade(Cancer Research UK Scotland Institute), Nicholas Rooney(Cancer Research UK Scotland Institute), Rosalie B. E. Willemsen(Cancer Research UK Scotland Institute)
Cited by 49
Related Papers
Targeting immunogenic cell death in cancer
|Molecular Oncology|2020|880
Mitochondrial apoptosis: killing cancer using the enemy within
|British Journal of Cancer|2015|794
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
|Cell stem cell|2019|552
Targeting BCL-2 regulated apoptosis in cancer
|Open Biology|2018|538
Mitochondrial inner membrane permeabilisation enables mt <scp>DNA</scp> release during apoptosis
|The EMBO Journal|2018|519